-
ST332 & ST409 Medical Statistics: 2023-2024 Assignment [20%] Deadline: 13:00 Friday 26Th April 2024Background Clinicians At University Hospitals Coventry & Warwickshire (UHCW) NHS Trust Have Studied Whether Elevated Levels (Above 2.9 Ng/Ml) Of A Biomarker, Carcinoembryonic Antigen (CEA), After Surg
2024/6/3 10:53:13
-
ST332 & ST409 - Medical Statisticspractical 5 - Meta-Analysismarson Et Al. (2001) Reported On A Systematic Review Of Four Anti-Epilepsy Drugs Which Had Been Introduced In The Late 20Th Century. The Article Is On The Moodle. Four Randomised Controlled Clinical Trials Had Been Published Which Compared...
2024/4/11 9:34:29
-
ST332 & ST409. Medical Statistics Practical 4 Parametric Survival Analysis And The Cox Proportional Hazards Model 1. Download The File Cpdat.Csv From The Moodle Page Containing Sur- Vival Data For Individuals With Cerebral Palsy [With Thanks To Pro- Fessor Pharoah For Allowing Us To Use These Data
2024/4/8 10:35:27
-
ST332/ST409 Medical Statistics 2023-24: Practical 31. Consider The Following Data Taken From A Study Taken From Patients Diagnosed With Pancreatic Cancer. The Data Are The Survival Times (In Months) Following Diagnosis With A Particular Variant For 10 Patients, Where * Indicates Right Censoring. D...
2024/4/6 10:43:43
-
ST332 & ST409 Medical Statistics: 2023-2024Assignment [20%]Deadline: 13:00 Friday 20Th April 2024Backgroundclinicians At University Hospitals Coventry & Warwickshire (UHCW) NHS Trust Have Studied Whether Elevated Levels (Above 2.9 Ng/Ml) Of A Biomarker, Carcinoembryonic Antigen (CEA), After Surgery
2024/4/5 11:12:45
-
ST332/ST409 Medical Statistics 2023-24: Practical 2Case-Control Study To Assess Risk Factors For Diagnosis Of Colorectal Cancer In Patients Diagnosed With Ulcerative Colitisthe Aim Of This Study Was To Assess Whether There Were Any Modifiable Risk Or Preventative Factors For Developing Colorectal Ca
2024/4/5 11:12:45
-
ST332/ST409 Medical Statistics 2023-24: Practical 1Clinical Efficacy Of Orlistat Therapy In Overweight And Obese Patients With Insulin-Treated Type 2 The Aim Of This Study Was To Assess The Effect Of Orlistat, A Gastrointestinal Lipase Inhibitor, On Weight Loss, Glycaemic Control, And Cardiovascular
2024/4/4 18:48:58
1